AMSTERDAM, March 16 (Reuters) - The European Medicines
Agency will hold a news conference later on Tuesday to discuss
its investigation into incidents of bleeding, blood clots and
low platelet counts in people who had been given AstraZeneca
PLC's coronavirus vaccine.
In a statement, the EMA said its Executive Director Emer
Cooke would give an update at a European Union Commission news
briefing at 1300 GMT.
(Reporting by Toby Sterling; Editing by Catherine Evans)